07/11/23View in Browser
Welcome to Euractiv's weekly Health newsletter bringing you the latest news from across Europe on the subject of Health.
Ad

Harness your organisation’s potential ahead of the 2024 changeover.

Explore effective ways to communicate and shape the narrative to achieve your goals

Access Euractiv’s report now! .

 Latest News
WHO lobbies EU lawmakers against watering down alcohol cancer risk on 07/11/23
In an unprecedented move, the World Health Organization (WHO) sent a letter –obtained by Euractiv– to MEPs ahead of a crucial European Parliament’s vote expressing “increasing concern” on the state of play of the EU’s flagship Beating Cancer plan due to a “scientifically inaccurate and worrisome” wording on alcohol use.
Young Dutch designer shows EU pharma the way in climate change fight on 06/11/23
With the Dutch healthcare sector responsible for 7% of all greenhouse gas emissions, pharmaceutical companies are joining the fight against climate change. On such an important mission, it’s all hands on deck and no one is too young to contribute.
Sweden expands use of spray that reverses opoid overdose on 06/11/23
The Swedish government says it will move quickly to make naloxone, a spray that rapidly reverses an opioid overdose, widely available outside the healthcare system in order to save more lives.
In France, gene therapy suffers from weak economic model on 03/11/23
France is one of the most advanced countries for gene therapies, both in Europe and worldwide. However, the lack of funding and the economic fragility of the sector are holding back the development of these innovative treatments.
Cancer therapy value assessments need renewal to keep pace with rapid scientific innovation [Promoted content] on 03/11/23
Innovation in science is advancing cancer care through early detection and treatment, bringing significant economic benefits to healthcare systems. Future incentives for innovation, particularly early detection and treatment approaches, must be recognised so that patients can benefit from this progress.
No decision in sight on whether to extend COVID-19 vaccine waiver on 02/11/23
No progress was made in discussions on whether to extend the COVID-19 vaccine waiver to include diagnostics and therapeutics at the latest meeting of trade officials.
Patient access to Slovak market’s most expensive drug remains blurry on 02/11/23
In Slovakia, a dispute has resurfaced over who should foot the bill for highly expensive drugs - with patients and their caregivers struggling under the unclear regulatory system.
Navigating care pathways for stroke survivors across the EU on 02/11/23
As the focus across the EU is usually on the prevention of stroke, post-stroke survivors are often left behind, without no national plans that take into account the need for a continuation of treatment after their discharge from medical institutions.
The lack of care for stroke survivors comes at a great cost on 02/11/23
Most European countries lack a plan for how to care for stroke survivors, missing out on an opportunity to ease a big burden weighing on already stretched health systems.
Hazardous substances in tattoo inks still exceed EU limits, Swedish agency warns on 02/11/23
Tattoo inks still contain potentially carcinogenic and allergenic substances in forbidden concentrations despite the introduction of an EU regulation in January 2022, according to an analysis by the Swedish Medical Products Agency.

Ad

Join us for the Congress of the Party of European Socialists

Europe in the lead: protecting citizens, promoting democracy and securing our position in the world. Progressive prime ministers, European Commissioners, and leaders meet in Spain.

Find out more here -> .

 Health Weekly 
Experts in Poland call for enhanced care in chronic pain conditions (02/11/23)
A calm before the storm (02/11/23)
Personal Doctors without specialty drafted to carry Greek primary health care (02/11/23)
Czech government bows to young doctors’ demands to rest after 24-hour shifts (02/11/23)
Amsterdam start-up receives funding to develop revolutionary type 1 diabetes treatment (02/11/23)
German pharma urges for EU-member states coordination in fresh health push (01/11/23)
Ireland’s medical technology drives country’s competitive advantage (01/11/23)
Experts call for revamp of pharma policies to ensure drug security (31/10/23)
Inaccurate data steering Bulgarian children’s health strategy, doctors warn (31/10/23)
Czech MPs concerned over EU pharma package marketing protection changes (30/10/23)
Macron paves way for France to become first to enshrine abortion in constitution (30/10/23)
Extension of COVID-19 vaccine waiver back on the table (27/10/23)
EU needs to step up to unleash gene therapies potential, stakeholders say (27/10/23)
The complexity and rewards of gene treatments for rare diseases (27/10/23)
Violence against women: Compromise not in sight (26/10/23)
EU Council reaches negotiating position on substances of human origin (26/10/23)
Rethinking global health initiatives in Astana (26/10/23)
EU institutions push for greater mental health protections in the workplace (25/10/23)
New genomic techniques – What lies ahead? (25/10/23)
EU Commission adopts set of actions to address critical medicine shortages (25/10/23)
What’s to come on health for the Spanish EU presidency (25/10/23)
Greek NHS to see radical reforms after years of stalemate (25/10/23)
Belgium: New agency to tackle fragmented health data collection (25/10/23)
Health committee approves final agreement on European Medicines Agency fees (24/10/23)
Irish doctors fume at government’s ‘insufficient’ 2024 health budget (24/10/23)
Poland’s biopharmaceutical innovation creates ‘win-win’ game for economy, patients (24/10/23)
Sale of antibiotics in Bulgaria fell with digital prescriptions (24/10/23)
Dutch cancer medication spending doubles over ten years (24/10/23)
Triage chatbot for patients under scrutiny in Sweden (24/10/23)
French medicine safety body issues warning for over-the-counter cold tablets (24/10/23)
Czech oncology boasts screening programs but lacks affordable medicines (23/10/23)
Netherlands identifies 11 health conditions with possible gaps in drug development (23/10/23)
New rules lowering asbestos exposure limits adopted (23/10/23)
Sweden’s snus EU future still uncertain amid tobacco directive evaluation (23/10/23)
Europe’s healthcare ambitions: right diagnosis, wrong treatment [Promoted content] (23/10/23)
EU countries criticised for patching up healthcare gaps through migration (19/10/23)
Global pandemic treaty proposal circulated, path to negotiations inches closer (18/10/23)
Health Brief: The moment of truth for global health action (18/10/23)
Germany urged to take action amid alarming antimicrobial resistance (18/10/23)
Greece aims for radical reforms in pharma sector, prioritise predictability (18/10/23)

Twitter
Instagram
Facebook
Website
LinkedIn
Spotify
YouTube
Euractiv Media Network BV: International Press Center Boulevard Charlemagne 1, Brussels, 1041 Belgium

Feedback    Unsubscribe    Health hub